Peiwei Chai

4.1k total citations · 2 hit papers
65 papers, 2.6k citations indexed

About

Peiwei Chai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Peiwei Chai has authored 65 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 20 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Peiwei Chai's work include RNA modifications and cancer (18 papers), Ocular Oncology and Treatments (12 papers) and Cancer-related molecular mechanisms research (10 papers). Peiwei Chai is often cited by papers focused on RNA modifications and cancer (18 papers), Ocular Oncology and Treatments (12 papers) and Cancer-related molecular mechanisms research (10 papers). Peiwei Chai collaborates with scholars based in China, United States and Poland. Peiwei Chai's co-authors include Xianqun Fan, Shengfang Ge, Renbing Jia, Jie Yu, Jing Ruan, Renbing Jia, Minyue Xie, Ruobing Jia, Ai Zhuang and Shaoyun Wang and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Molecular Cell.

In The Last Decade

Peiwei Chai

60 papers receiving 2.6k citations

Hit Papers

Histone lactylation drives oncogenesis by facilitating m6... 2021 2026 2022 2024 2021 2025 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peiwei Chai China 24 1.8k 1.0k 455 247 188 65 2.6k
Jianfeng Shen China 21 1.2k 0.7× 359 0.3× 742 1.6× 363 1.5× 76 0.4× 63 2.1k
Qi Zhou China 26 938 0.5× 518 0.5× 872 1.9× 438 1.8× 24 0.1× 99 2.2k
Alessandra Romano Italy 30 890 0.5× 189 0.2× 721 1.6× 644 2.6× 64 0.3× 187 2.6k
Mohamed H. Abdel‐Rahman United States 24 943 0.5× 266 0.3× 637 1.4× 406 1.6× 983 5.2× 81 2.4k
Augustin Amour United Kingdom 22 1.0k 0.6× 921 0.9× 784 1.7× 291 1.2× 40 0.2× 48 2.4k
Bin Shan United States 32 2.1k 1.2× 1.4k 1.3× 646 1.4× 327 1.3× 29 0.2× 72 3.4k
Shakeel Modak United States 37 1.7k 0.9× 869 0.8× 1.5k 3.4× 758 3.1× 55 0.3× 160 4.7k
Hedwig E. Deubzer Germany 31 2.9k 1.7× 545 0.5× 1.1k 2.4× 155 0.6× 21 0.1× 64 3.7k
Deborah A. Tweddle United Kingdom 28 1.3k 0.7× 709 0.7× 854 1.9× 112 0.5× 24 0.1× 64 2.2k

Countries citing papers authored by Peiwei Chai

Since Specialization
Citations

This map shows the geographic impact of Peiwei Chai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiwei Chai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiwei Chai more than expected).

Fields of papers citing papers by Peiwei Chai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiwei Chai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiwei Chai. The network helps show where Peiwei Chai may publish in the future.

Co-authorship network of co-authors of Peiwei Chai

This figure shows the co-authorship network connecting the top 25 collaborators of Peiwei Chai. A scholar is included among the top collaborators of Peiwei Chai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiwei Chai. Peiwei Chai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jie, Ziyue Huang, Hao Tian, et al.. (2025). Lactate and lactylation in cancer. Signal Transduction and Targeted Therapy. 10(1). 38–38. 116 indexed citations breakdown →
2.
Yang, Jie, Hanhan Shi, Yongyun Li, et al.. (2025). Aurora A Kinase Inhibition Is Synthetic Lethal With the Activation of MYCN in Retinoblastoma. Investigative Ophthalmology & Visual Science. 66(2). 20–20.
4.
He, Xiaoyu, Yangfan Xu, Peiwei Chai, et al.. (2025). A Penetrable AAV2 Capsid Variant for Efficient Intravitreal Gene Delivery to the Retina. Investigative Ophthalmology & Visual Science. 66(1). 6–6. 1 indexed citations
5.
Zhang, Lingyu, Hui Pan, Yiran Yao, et al.. (2024). Gain of chromosome 8q and high expression of EZH2 may predict poor prognosis in Chinese patients with uveal melanoma. Asia-Pacific Journal of Ophthalmology. 13(5). 100108–100108.
6.
Li, Te, Peiwei Chai, Qinghua Qiu, et al.. (2024). Is longer axial length protective of vision-threatening diabetic retinopathy across different ages? A multicenter cohort of 736 patients. International Journal of Retina and Vitreous. 10(1). 74–74. 1 indexed citations
7.
Shi, Hanhan, Tianyu Zhu, Chang Liu, et al.. (2024). Single-cell sequencing depicts tumor architecture and empowers clinical decision in metastatic conjunctival melanoma. Cell Discovery. 10(1). 63–63. 6 indexed citations
8.
Shi, Hanhan, Xiaoyu He, Zhi Yang, et al.. (2023). The Use of rAAV2-RB1–Mediated Gene Therapy in Retinoblastoma. Investigative Ophthalmology & Visual Science. 64(15). 31–31. 3 indexed citations
9.
Zhuang, Ai, Xiang Gu, Tongxin Ge, et al.. (2023). Targeting histone deacetylase suppresses tumor growth through eliciting METTL14‐modified m 6 A RNA methylation in ocular melanoma. Cancer Communications. 43(11). 1185–1206. 21 indexed citations
10.
Gu, Xiang, Ai Zhuang, Jie Yu, et al.. (2023). Histone lactylation-boosted ALKBH3 potentiates tumor progression and diminished promyelocytic leukemia protein nuclear condensates by m1A demethylation of SP100A. Nucleic Acids Research. 52(5). 2273–2289. 80 indexed citations
11.
Gu, Xiang, Ziyue Huang, Jie Chen, et al.. (2023). Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line. Investigative Ophthalmology & Visual Science. 64(15). 16–16. 1 indexed citations
12.
Yu, Jie, Ai Zhuang, Xiang Gu, et al.. (2023). Nuclear PD-L1 promotes EGR1-mediated angiogenesis and accelerates tumorigenesis. Cell Discovery. 9(1). 33–33. 59 indexed citations
13.
Luo, Yingxiu, Jie Yang, Feifei Zhang, et al.. (2023). A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m6A -dependent activation of multiple oncogenes. Science China Life Sciences. 66(9). 2138–2151. 18 indexed citations
14.
Ge, Tongxin, Xiang Gu, Renbing Jia, et al.. (2022). Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities. Cancer Communications. 42(11). 1049–1082. 114 indexed citations
15.
Gu, Xiang, Jie Yu, Ludi Yang, et al.. (2022). Epigenetic drug library screening reveals targeting DOT1L abrogates NAD+ synthesis by reprogramming H3K79 methylation in uveal melanoma. Journal of Pharmaceutical Analysis. 13(1). 24–38. 8 indexed citations
16.
Chai, Peiwei, Pengfei Lan, Shaobai Li, et al.. (2022). Mechanistic insight into allosteric activation of human pyruvate carboxylase by acetyl-CoA. Molecular Cell. 82(21). 4116–4130.e6. 19 indexed citations
17.
Chai, Peiwei, Ruobing Jia, Yongyun Li, et al.. (2021). Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma. Progress in Retinal and Eye Research. 89. 101030–101030. 34 indexed citations
18.
Chai, Peiwei, Jie Yu, Yue Xing, et al.. (2020). LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter. Cell Death and Disease. 11(5). 306–306. 27 indexed citations
19.
Li, Yongyun, Yang Liu, Jie Yang, et al.. (2020). A novel variant in GPAA1, encoding a GPI transamidase complex protein, causes inherited vascular anomalies with various phenotypes. Human Genetics. 139(12). 1499–1511. 6 indexed citations
20.
Chai, Peiwei, et al.. (2016). The Evolving Functions of Autophagy in Ocular Health: A Double-edged Sword. International Journal of Biological Sciences. 12(11). 1332–1340. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026